Tag: TOMDF

Persistent Options Success & More

Another Clean Sweep on Options: 

We’ve been rattling off some excellent options opportunities for our readers this week, and yesterday was another hallmark performance on our part. We slated three sets of fresh options contracts for observation in our premarket report yesterday morning, and each one recorded a solid intraday move for us.

We were targeting the AMC Weekly $44-46 Calls, the DKS Weekly $122-130 Calls, and the KC 09/17 $30-35 Calls, and for the second consecutive session we picked a trio of winners and were treated to solid intraday profit chances across the board.

The daily ranges and total possible gains on those targets were as follows: 

AMC Weekly $44-46 Calls
$44: 3.30-7.20 (+118%)
$45: 2.99-6.60 (+121%)
$46: 2.80-6.20 (+121%)
_____

DKS Weekly $122-130 Calls
$122: 8.26-12.90 (+56%)
$125: 5.34-10.38 (+94%)
$130: 3.01-6.60 (+119%)
_____

KC 09/17 $30-35 Calls
$30: 1.25-2.20 (+76%)
$35: .39-.60 (+76%)

Fresh Options Ideas:
SAVA 09/10 $93-94 Calls
ULTA Weekly $405-415 Calls
CRM Weekly $262.50-270 Calls 

Extended Watchlist:
YY, GSMG, RIDE, UUU, ZOM, BLUW, ILUS, KYNC, TOMDF, IQST, FORW. STSN, BRGO, HBRM

TOMDF Run Continues

Todos Medical, Ltd. TOMDF

We have been tracking TOMDF since Tuesday morning in the premarket, when we included it in our extended watchlist. At the time, it was trading for as little as .0413 per share, and while it had a solid session that day, the gains hadn’t quite yet cracked the double-bag threshold.

Yesterday, after another really good performance, that mark was attained and then some. TOMDF has gone on to hit a new high of .17 for us, which works out to a big gain of 312%

The company’s rapid (2-10min) COVID-19 point-of-care test has been the primary reason for the stock’s huge moves. We will stay updated on the progress of the company getting the tests put into action, and will be interested to see if more upswings are on the horizon as a result.

Options Recaps

We signaled a range of options in the GILD chain in yesterday morning’s report. with the GILD Weekly $79-81 Calls. Thanks to a pretty good day for the markets, all things considered, we witnessed some very nice moves out of those targets.

Weekly $79-81 Calls
$79: 3.44-8.00 (+133%)
$80: 2.68-7.42 (+177%)
$81: 2.49-6.05 (+143%)
_____

Fresh Ideas:
CRWD Weekly $47.50-50 Calls & 03/27 $52-53.50 Calls

Extended Watchlist:
TNXP, NBP, WTRH, BLPH, AMTX, PIXY, CEMI

Coronavirus Watchlist & More

Todos Medical, Ltd. TOMDF

The see-saw of market volatility persists with no end in sight. Traditional investing has become a fool’s errand in many, if not most, cases. The kind of opportunistic short term trading that we do is relatively intact, with the right targets and scenarios.

In this case, we caught TOMDF’s coronavirus news in the premarket yesterday, stating that the company had secured distribution agreements for testing kits in both the US and Isreal. After including it in our extended watchlist, the stock managed a very nice intraday gain. It traded up from a low of  0413, and reached a high of .08, which works out to an intraday upswing of 94%

Coronavirus Watchlist

While we do focus primarily on quick strike opportunities, it’s also worth it to mention a few plays that represent products and services that are high demand at the present time due to the fallout from COVID-19. If the report from the UK’s highly respected Imperial College is accurate, this global health crisis is only in its beginning stages, and will get much, much worse in the months ahead.

While neither these, nor any other plays are “corona-proof”, the effects may weigh less heavily on these stocks and those like them:

CPB, APRN, CLX, GIS, PG

Extended Watchlist:
MATN, ZOOM, DECN, PCTL, NBDR, IPIX, GNPX, GNBT